Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 68
Filtrar
2.
Can J Plast Surg ; 19(3): 77-81, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22942654

RESUMO

BACKGROUND: Cutaneous melanoma dermal invasion, identified through measurement of maximum tumour thickness and sentinel lymph node (SLN) biopsy, is important to establish melanoma prognosis and progression. P16 protein expression has been shown to be a predictive factor for melanoma evolution and prognosis. OBJECTIVE: To investigate p16 protein expression in cutaneous melanomas with and without SLN metastasis. PATIENTS AND METHODS: Sixty-seven paraffin-embedded cutaneous melanoma specimens of patients who had undergone SLN investigation were evaluated from 1995 to 2007. SLN biopsy was negative for metastasis in 34 of these patients (controls); in the remaining 33 patients, SLN biopsy was positive (cases). The expression of p16 protein in the primary tumour was measured using an immunohistochemical assay. The samples were classified according to their nuclear expression. RESULTS: P16 nuclear expression was absent in 14 cases and in 15 controls; P=0.812. There was no statistically significant difference in p16 nuclear expression between cases and controls. CONCLUSIONS: The present study does not support the findings of other studies that suggest p16 protein expression is important in the prognosis of cutaneous melanoma.

4.
J Eur Acad Dermatol Venereol ; 23(3): 304-7, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19207653

RESUMO

BACKGROUND: Similar to other countries, incidence and mortality rates for cutaneous melanoma (CM) are increasing in Brazil. Resulting from centuries of ethnic mixture, the skin of the Brazilian population presents all phototypes, being progressively lighter following the increase of the latitude toward the South, where the highest incidence of melanoma is observed. Studies from the United States and Argentina in whites suggest that European ancestry could represent an important risk factor for CM in those regions. METHODS: Questionnaires from a case-control study involving 119 melanoma patients and 177 controls were reviewed for age, gender, phototype, sun exposure, photoprotection and ancestry. The patients reported the countries of ancestry of their grandparents. Data were tabulated and converted into scores that would reflect the proportion of ancestry for each country in individuals. RESULTS: Patients with German and Italian ancestry presented higher risk for CM [odds ratio (OR), 3.5; 95% confidence interval (95% CI), 1.8-6.7 and OR, 9.7; 95% CI, 3.9-24.2, respectively]. Conversely, Brazilian indigenous ancestry showed a protective effect for the development of the disease, with an OR of 0.16 (95% CI, 0.04-0.7). CONCLUSIONS: Some European ancestries, especially German and Italian, seem to be associated to a higher risk of CM in this sample from Southern Brazil. On the other hand, Brazilian indigenous ancestry presented as a protection factor against developing the tumour.


Assuntos
Melanoma/epidemiologia , Neoplasias Cutâneas/epidemiologia , População Branca , Adulto , Brasil/epidemiologia , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários
9.
J Telemed Telecare ; 9 Suppl 1: S9-12, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12952705

RESUMO

We established a Website which allowed clinical dermatology cases to be submitted, with digital images, through a simple online form. The case could then be managed within the public health service. A database containing 6000 drug interactions was also available on the Website to help clinical management. The Website was tested by 10 junior doctors, who examined dermatology patients, filled in the electronic form with their clinical observations and descriptions, and forwarded digital images. Five dermatologists then evaluated the 71 cases stored on the Website. The agreement between the virtual evaluation and the definitive diagnosis (on face-to-face examination) was 95%. The Website could be used in national health strategies, as a tool for promoting voluntary medical attendance, and for multicentre epidemiological surveillance.


Assuntos
Dermatologia/normas , Internet/normas , Consulta Remota/normas , Dermatopatias/diagnóstico , Bases de Dados como Assunto/normas , Humanos
12.
Rev Assoc Med Bras (1992) ; 45(1): 9-14, 1999.
Artigo em Português | MEDLINE | ID: mdl-10436587

RESUMO

OBJECTIVES: To analise the etiological association of Hp and Idiopathic Chronic Urticaria (UCI). MATERIAL AND METHODS: Case control study. Eighteen patients over 18 years with clinical and laboratory evidences of ICU have been studied. Previous exposure to Hp was evaluated by serum IgG for Hp. The control group, with 18 patients were paired to age, sex, race and social economic conditions. In the patients positive to Hp oral doses of amoxacilin, metronidazole and omeoprazole were given in order to eradicate the agent. RESULTS: Twelve patients with UCI were positive to Hp (66.7%) and 6 were positive in the control group (33.3%). In the cases treated to eradicate Hp 6 had complete remission, 4 parcial remission and 2 had no improve. CONCLUSION: There are strong evidences that Hp is an etiological factor of Urticaria. In our study the difference of 33.4% in the previous exposure to Hp between cases and controls and the positive results with the therapeutics confirm the existence of this etiological association.


Assuntos
Helicobacter pylori/isolamento & purificação , Urticária/microbiologia , Adulto , Antibacterianos/uso terapêutico , Antiulcerosos/uso terapêutico , Estudos de Casos e Controles , Doença Crônica , Feminino , Infecções por Helicobacter/tratamento farmacológico , Humanos , Masculino , Metronidazol/uso terapêutico , Pessoa de Meia-Idade , Omeprazol/uso terapêutico
13.
Rev. Assoc. Med. Bras. (1992) ; 45(1): 9-14, jan.-mar. 1999.
Artigo em Português | LILACS | ID: lil-233202

RESUMO

Objetivo. Analisar a possível associaçao de nexo causal entre o Hp e Urticária Crônica Idiopática (UCI). Material e Métodos. Estudo de casos e controles. Foram estudados 18 pacientes, maiores de 18 anos, com quadro clínico e laboratorial de UCI. A exposiçao prévia ao Hp foi avaliada pela realizaçao de sorologia por radioimunoensaio (IgG para Helicobacter pylori). O grupo-centrole, composto por 18 integrantes, foi emparelhado para idade, sexo, raça e condiçoes sócio-econômicas. Nos pacientes soro-reagentes, instituiu-se tratamento para a erradicaçao do Hp, com doses orais de amoxacilina, metronidazol e omeprazol sendo o seguimento realizado por dois meses. Resultados. Entre os pacientes com UCI, 12 foram soro-reagentes para Hp (66,7 por cento) e entre os controles 6 foram soro-reagentes (33,3 por cento). Dos casos tratados para a erradicaçao do Hp 6 obtiveram remissao completa, 4 obtiveram remissao parcial e 2 nao obtiveram melhora alguma. Conclusoes. As evidências de que o Hp constitui-se em um dos fatores etiológicos dos quadros urticarianos vêm se fortalecendo e, em nosso trabalho, a diferença de quase 30 por cento na exposiçao prévia ao Hp entre casos e controles, somada com os resultados na terapêutica e no seguimento, corroboram as expectativas da existência deste nexo causal.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Helicobacter pylori/isolamento & purificação , Urticária/microbiologia , Anti-Infecciosos/uso terapêutico , Antiulcerosos/uso terapêutico , Estudos de Casos e Controles , Doença Crônica , Infecções por Helicobacter/tratamento farmacológico , Metronidazol/uso terapêutico , Omeprazol/uso terapêutico
14.
J Clin Pharmacol ; 38(6): 554-60, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9650546

RESUMO

Tramadol hydrochloride is a novel, centrally acting analgesic with two complementary mechanisms of action: opioid and aminergic. Relative to codeine, tramadol has similar analgesic properties but may have fewer constipating, euphoric, and respiratory depressant effects. A two-center randomized double-blind controlled clinical trial was performed to assess the analgesic efficacy and reported side effects of tramadol 100 mg, tramadol 50 mg, codeine 60 mg, aspirin (ASA) 650 mg with codeine 60 mg, and placebo. Using a third molar extraction pain model, 200 healthy subjects were enrolled in a 6-hour evaluation after a single dose of drug. Of the 200 patients enrolled, seven provided incomplete efficacy data or discontinued prematurely and one was lost to follow-up. Using standard measures of analgesia, including total pain relief score (TOTPAR), maximum pain relief score (MaxPAR), sum of pain intensity difference scores (SPID), peak pain intensity difference (Peak PID), remedication, and global evaluations, all active treatments were found to be numerically superior to placebo. ASA/codeine was found to be statistically superior to placebo for all measures of efficacy. Tramadol 100 mg was statistically superior to placebo for TOTPAR, SPID, and time of remedication, whereas tramadol 50 mg was statistically superior to placebo onlyfor remedication time. Codeine was not found to be statistically superior to placebo for any efficacy measure. A greater TOTPAR response compared with all other active measures was seen for ASA/codeine during the first 3 hours of study. The 6-hour TOTPAR scores for the tramadol groups and ASA/ codeine group were not significantly different. Gastrointestinal side effects (nausea, dysphagia, vomiting) were reported more frequently with tramadol 100 mg, ASA/ codeine, and codeine 60 mg than with placebo.


Assuntos
Analgésicos Opioides/uso terapêutico , Dor Pós-Operatória/tratamento farmacológico , Extração Dentária , Tramadol/uso terapêutico , Adolescente , Adulto , Idoso , Analgesia , Análise de Variância , Anti-Inflamatórios não Esteroides/uso terapêutico , Aspirina/administração & dosagem , Aspirina/uso terapêutico , Codeína/administração & dosagem , Codeína/uso terapêutico , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
15.
Orv Hetil ; 139(8): 415-8, 1998 Feb 22.
Artigo em Húngaro | MEDLINE | ID: mdl-9524424

RESUMO

The aim of the study was to determine the fetal and neonatal outcomes of pregnancies conceived during the inactive phase of systemic lupus erythematosus (SLE). Fetal and neonatal outcomes in 75 pregnancies of 33 patients with SLE were analyzed. In 19 patients (57.6%) the SLE also had hematological autoimmune presentations prior to gestation, such as anemia, thrombopenia, garnulocytopenia, and antiphospholipid antibody and/or lupus anticoagulant (APA). Out of 75 pregnancies, 19 elective terminations were carried out because the disease was active or for non-medical reasons. The adverse fetal outcomes of those 56 pregnancies which occurred during the inactive phase were compared with those of the control patients. In SLE, the rates of spontaneous abortions (46.4%) and newborns with low (< 2500 gr) birthweight (36.7%) were found to increase roughly three times that of the controls and the perinatal fetal loss (16.7%) also increased significantly as compared with the control group (28.5 per thousand). APA noted at any time before pregnancy increased the low birthweight rate (75%) six fold and the perinatal loss (33.3%) more than ten fold but did not affect the rate of spontaneous abortions. Any kind of hemocytopenias without APA, noted before pregnancy did not worsen the fetal outcome in SLE. Neonatal lupus was diagnosed in 2 out of the 30 newborns. Our results suggest that among the hematologic manifestations of SLE presenting before pregnancy, APA can predict the high risks of low birthweight and perinatal fetal loss as opposed to hemocytopenias.


Assuntos
Retardo do Crescimento Fetal , Lúpus Eritematoso Sistêmico , Complicações Hematológicas na Gravidez , Aborto Induzido , Feminino , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Gravidez , Resultado da Gravidez
16.
Pediatr Infect Dis J ; 16(6): 545-8, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9194102

RESUMO

BACKGROUND: Topical application of antifungal agents is considered the treatment of choice for dermatomycoses. Most of the available drugs are fungistatic, requiring long term treatment to prevent relapses. Terbinafine is a synthetic antifungal agent that, because of its fungicidal action, provides high cure rates and low relapse rates after short periods of treatment. METHODS: Ninety-seven children ages 2 to 15 years with a suspected diagnosis of tinea corporis and/or tinea cruris were enrolled in this open trial. After mycologic assessment to confirm diagnosis (culture and direct microscopy) terbinafine 1% cream was applied once daily during 1 week. Clinical and mycologic assessments were made at the baseline visit and on Days 7, 14 and 21. Efficacy assessment was based on 88 children (9 patients excluded by protocol violation). RESULTS: Therapy was considered effective in 92.0% (81 of 88) of patients (complete clinical and mycologic cure or mycologic cure with minimum signs and symptoms or clinical improvement, > or = 50%). Tolerability was assessed in 97 patients on an intention-to-treat basis. Adverse reactions were itching 3% (3 of 97), itching associated with erythema exacerbation 1% (1 of 97) and contact dermatitis 1% (1 of 97). CONCLUSION: Terbinafine 1% cream appears to be an effective and well-tolerated treatment for tinea corporis and tinea cruris in children.


Assuntos
Antifúngicos/uso terapêutico , Naftalenos/uso terapêutico , Tinha/tratamento farmacológico , Administração Tópica , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Naftalenos/administração & dosagem , Naftalenos/efeitos adversos , Terbinafina , Tinha/microbiologia
19.
Lepr Rev ; 66(4): 277-86, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8637381

RESUMO

Sixty skin biopsies taken from positive tuberculoid and borderline-tuberculoid late lepromin reaction were studied using histological techniques. The distribution of mycobacterial antigen and nerves was demonstrated using immunochemical methods. A total of 557 nerve bundles was observed in 51 biopsies; 9 were devoid of nerves in the sections examined; 475 nerve bundles showed some relationship to the inflammatory infiltrate (85%); perineuritis being seen in 144 (30%) and endoneuritis in 5 (0.9%). Mycobacterial antigens inside the granuloma were detected in 59 of the 60 biopsies (98%). Only one specimen, showing a strong tuberculoid reaction, failed to show these antigens. On the contrary, mycobacterial antigen was absent in almost all nerves. Small deposits were detected in the perineurium of one nerve with perineuritis, and inside a Schwann cell of another, the latter belonging to a previously multibacillary patient. The neurotropic tendency of the granuloma does not seem to be stimulated by the presence of mycobacterial antigens inside the nerves, as normally these antigens do not penetrate them. The hypothesis of some antigenic fraction of the neural tissue which cross-reacts with Mycobacterium leprae antigens, thus eliciting a perineural or near-perineural inflammatory reaction is put forward, but needs further investigation.


Assuntos
Hanseníase/complicações , Neurite (Inflamação)/diagnóstico , Pele/inervação , Antígenos de Bactérias/análise , Humanos , Imuno-Histoquímica , Antígeno de Mitsuda , Neurite (Inflamação)/complicações , Neurite (Inflamação)/microbiologia
20.
J Invest Dermatol ; 105(1): 8-13, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7615981

RESUMO

Ultraviolet radiation (UVR) modulates cellular immunity in humans and experimental animals and can interfere with immune responses against infectious agents in animal models. We used the lepromin reaction, a cell-mediated immune response to antigens of Mycobacterium leprae, to determine whether UVR affects the cellular immune response to an infectious agent in humans. We selected 29 healthy, lepromin-positive contacts of leprosy patients and determined their minimal erythema dose (MED) of UVR. Immediately afterward, each subject was injected with 0.1 ml of lepromin in two areas of the buttocks: one at the site that had received twice the MED of UVR and the other on the contralateral, unirradiated site. The irradiated site was given twice the MED every 4 d for a total of five treatments. One week after the last irradiation, both lepromin reactions were measured and biopsied. The size of the lepromin-induced granulomas was significantly reduced in the irradiated site, as was the number of lymphocytes. Immunohistochemical analysis showed a depletion in the number of infiltrating cells and a lower percentage of T cells, particularly the CD4+ subpopulation, in granulomas formed in UV-irradiated skin. This study demonstrates that local UV irradiation reduces the granulomatous reaction to lepromin in sensitized individuals. These findings are of clinical relevance because of the fundamental role played by the delayed-type hypersensitivity response in defense against intracellular pathogens and because of potential increases in the amount of UVR in sunlight reaching the earth's surface.


Assuntos
Granuloma/imunologia , Imunidade Celular/efeitos da radiação , Antígeno de Mitsuda/imunologia , Raios Ultravioleta , Adolescente , Adulto , Animais , Feminino , Humanos , Hipersensibilidade Tardia , Masculino , Camundongos , Pessoa de Meia-Idade , Pele/imunologia , Pele/efeitos da radiação , Linfócitos T/efeitos da radiação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...